These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2153229)

  • 1. Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor.
    Donta ST; Shanley JD
    J Virol; 1990 Feb; 64(2):639-41. PubMed ID: 2153229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity binding of reovirus type 3 to cells that lack beta adrenergic receptor activity.
    Sawutz DG; Bassel-Duby R; Homcy CJ
    Life Sci; 1987 Jan; 40(4):399-406. PubMed ID: 3027484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the beta-adrenergic receptor function as a reovirus receptor?
    Choi AH; Lee PW
    Virology; 1988 Mar; 163(1):191-7. PubMed ID: 2831655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors.
    Co MS; Gaulton GN; Tominaga A; Homcy CJ; Fields BN; Greene MI
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5315-8. PubMed ID: 2991918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterization of skeletal muscle beta-adrenergic receptors coupled to adenylate cyclase.
    Reddy NB; Engel WK
    Biochim Biophys Acta; 1979 Jul; 585(3):343-59. PubMed ID: 226166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two beta-adrenergic pharmacophores on the same molecule. A set of agonist-antagonist combinations.
    Kusiak JW; Heja G; Pitha J
    Biochem Pharmacol; 1987 Jan; 36(2):269-75. PubMed ID: 2880591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exfoliation of the beta-adrenergic receptor and the regulatory components of adenylate cyclase by cultured rat glioma C6 cells.
    Kassis S; Lauter CJ; Stojanov M; Salem N
    Biochim Biophys Acta; 1986 May; 886(3):474-82. PubMed ID: 2871868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
    Chen FC; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1982 Jul; 222(1):7-13. PubMed ID: 6283073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the beta-adrenergic responsiveness between high and low passage rat glioma C6 cells.
    Mallorga P; Tallman JF; Fishman PH
    Biochim Biophys Acta; 1981 Dec; 678(2):221-9. PubMed ID: 6274415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
    Williams LT; Gore TB; Lefkowitz RJ
    J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta adrenergic receptor repopulation of C6 glioma cells after irreversible blockade and down regulation.
    Homburger V; Pantaloni C; Lucas M; Gozlan H; Bockaert J
    J Cell Physiol; 1984 Dec; 121(3):589-97. PubMed ID: 6094600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible blockade of beta-adrenergic receptors with a bromoacetyl derivative of pindolol.
    Homburger V; Gozlan H; Bouhelal R; Lucas M; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):279-87. PubMed ID: 2858822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hormone-independent rise of adenosine 3',5'-monophosphate desensitizes coupling of beta-adrenergic receptors to adenylate cyclase in rat glioma C6-cells.
    Koschel K
    Eur J Biochem; 1980; 108(1):163-9. PubMed ID: 6157529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of (-)-[3H]dihydroalprenolol to study beta adrenergic receptor-adenylate cyclase coupling in C6 glioma cells: role of 5'-guanylylimidodiphosphate.
    Lucas M; Bockaert J
    Mol Pharmacol; 1977 Mar; 13(2):314-29. PubMed ID: 192993
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the desensitization of beta-adrenergic receptors by [3H]CGP-12177.
    Hertel C; Müller P; Portenier M; Staehelin M
    Biochem J; 1983 Dec; 216(3):669-74. PubMed ID: 6141790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The resolution of dopamine and beta 1- and beta 2-adrenergic-sensitive adenylate cyclase activities in homogenates of cat cerebellum, hippocampus and cerebral cortex.
    Dolphin A; Hamont M; Bockaert J
    Brain Res; 1979 Dec; 179(2):305-17. PubMed ID: 41616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-adrenergic receptor system in human glioma-derived cell lines: the mode of phosphodiesterase induction and the macromolecules phosphorylated by cyclic AMP-dependent protein kinase.
    Shitara N; Reisine TD; Nakamura H; Fujiwara M; Smith BH; Kornblith PL; McKeever PE
    Brain Res; 1984 Mar; 296(1):67-74. PubMed ID: 6324958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel modulation of catecholamine activation of adenylate cyclase and formation of the high-affinity agonist.receptor complex in turkey erythrocyte membranes by temperature and cis-vaccenic acid.
    Briggs MM; Lefkowitz RJ
    Biochemistry; 1980 Sep; 19(19):4461-6. PubMed ID: 6250586
    [No Abstract]   [Full Text] [Related]  

  • 20. Turn on and turn off reactions of beta-adrenergic-sensitive adenylate cyclase in control and desensitized C6 glioma cells.
    Homburger V; Lucas M; Bockaert J
    FEBS Lett; 1982 May; 141(2):245-50. PubMed ID: 6124458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.